logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Influenza Advances In Diagnosis And Management 1st Ed Jiro Fujita

  • SKU: BELL-22474050
Influenza Advances In Diagnosis And Management 1st Ed Jiro Fujita
$ 31.00 $ 45.00 (-31%)

4.4

32 reviews

Influenza Advances In Diagnosis And Management 1st Ed Jiro Fujita instant download after payment.

Publisher: Springer Singapore;Springer
File Extension: PDF
File size: 7.85 MB
Author: Jiro Fujita
ISBN: 9789811591082, 9789811591099, 9811591083, 9811591091
Language: English
Year: 2021
Edition: 1st ed.

Product desciption

Influenza Advances In Diagnosis And Management 1st Ed Jiro Fujita by Jiro Fujita 9789811591082, 9789811591099, 9811591083, 9811591091 instant download after payment.

This book explores the latest research and practical data on the clinical management of influenza. Starting with the definition, epidemiology and pathogenesis, the first part reviews the basic science of the influenza virus and infection. The next three parts then discusses the diagnosis, complications and management, providing practical data and insights that are useful in day-to-day patient care. The last part focuses on the trending topics, including a new drug, oral baloxavir marboxil, which was introduced in Japan in 2018 and is the first polymerase inhibitor to be licensed for the treatment of uncomplicated influenza. In Japan, since the medical insurance system is well-established, patients receive medical examinations quickly after the onset of influenza viral infection, making it easy to implement early diagnostic tools and early treatment. Providing practical data and insights, Influenza - Advances in Diagnosis and Management is a useful resource for clinicians, residents and trainees around the globe.

Related Products